The United Kingdom is seeing a remarkable evolution in its perception towards mind-altering substances. What began with a subtle exploration of ‘shrooms’ and commonplace ceremonial brews is now developing to encompass more experimental substances like copyright and though research into clinical uses. This rising interest is fuelled by growing p